Variant Creutzfeldt-Jakob disease: Pathology, epidemiology, and public health implications

American Journal of Clinical Nutrition

Volumn 78, Issue 3 SUPPL., 2003, Pages

  Trevitt, Clare R ^a   Singh, Pramil N ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Meat; Prion disease; Spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

PRION PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY; CELL DEATH; CLINICAL FEATURE; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIET; HUMAN; INCIDENCE; MEAT; NONHUMAN; PATHOPHYSIOLOGY; PRION DISEASE; PUBLIC HEALTH; ANIMAL; CATTLE; DISEASE TRANSMISSION; PATHOLOGY; REVIEW; UNITED KINGDOM;

ANIMALIA; BOVINAE; OVIS ARIES;

ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; DIET; ENCEPHALOPATHY, BOVINE SPONGIFORM; GREAT BRITAIN; HUMANS; INCIDENCE; PUBLIC HEALTH;

EID: 0043286250     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/78.3.651s     Document Type: Conference Paper

References (79)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-44.
2. McGowan JP. Scrapie in sheep. Scott J Agric 1992;5:365-75.
3. Marsh RF. Transmissible mink encephalopathy. In: Prusiner SB, Collinge J, Powell J, Anderton B, eds. Prion diseases in humans and animals. London: Ellis Horwood, 1992:300-7.
4. Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 1980;16:89-98.
5. Wells GAH, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987;31:419-20.
6. Wilesmith JW, Wells GA, Cranwell MP, Ryan JB. Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 1988;123:638-44.
7. Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382:779-88
8. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-90.
9. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-50.
10. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997; 389:498-501.
11. Andrews NJ, Farrington CP, Consens SN, et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000;356(9228):481-2.
12. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982;218:1309-11.
13. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K. NMR structure of the mouse prion protein domain PrP (121-231). Nature 1996;382:180-2.
14. James TL, Liu H, Ulyanov NB, et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A 1997;94: 10086-91.
15. Zahn R, Liu A, Luhrs T, et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 2000;97:145-50.
16. Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990;110:743-52.
17. Caughey B, Raymond GJ. The scrapie associated form of PrP is made from a cell surface precursor that is both protease and phospholipase-sensitive. J Biol Chem 1991;266:18217-23.
18. Stahl N, Baldwin MA, Teplow DB, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993;32:1991-2002
19. Pan K-M, Baldwin MA, Nguyen J, et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993;90:10962-6.
20. Griffith JS. Self-replication and scrapie. Nature 1967;215:1043-4.
21. Collinge J. Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet 1997;6:1699-705.
22. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991;352:340-2.
23. Prusiner SB, Scott M, Foster D, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990;63:673-86.
24. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993;73:1339-47.
25. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994;370:471-4.
26. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT Jr, Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A 1995;92:3923-7.
27. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995;375:698-700.
28. Milner J, Medcalf EA. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 1991;65(5):765-74.
29. Osherovich LZ, Weissman JS. The utility of prions. Dev Cell 2002; 2:143-51.
30. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci U S A 2002;99(11):7402-7.
31. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24:519-50.
32. Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 1966;209:794-6.
33. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
34. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
35. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991;337:1441-2.
36. Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996;98:259-64.
37. Baker HE, Poulter M, Crow TJ, et al. Aminoacid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 1991;337:1286 (letter).
38. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples Lancet 1999;353:183-9.
39. UK Government Department of Health. CJD statistics. July 2002. Internet: http://www.doh.gov.uk/cjd/stats/jul02.htm (accessed 31 July 2002).
40. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-82.
41. Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80.
42. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895-904.
43. Horn G. Review of the origin of BSE. July 2001. Internet: http:// www.defra.gov.uk/animalh/bse/bseorigin.pdf (accessed 31 July 2002).
44. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 1994;343:405-11.
45. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999;354: 317-23.
46. Office international des Épizootics (World Organization for Animal Health). Number of cases of bovine spongiform encephalopathy (BSE) reported in the United Kingdom. July 2002. Internet: http:// www.oie.int/eng/info/en_esbru. htm (accessed 31 July 2002).
47. Office international des Épizootics (World Organization for Animal Health). Annual incidence rate of bovine spongiform encephalopathy (BSE) in countries that have reported cases. June 2002. Internet: http: //www.oie.int/eng/info/en_esbincidence.htm (accessed 31 July 2002).
48. UK Government Department of the Environment. Food and Rural Affairs website. July 2002. Internet: http://www.defra.gov.uk/animalh/ bse/index.html (accessed 31 July 2002).
49. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-78.
50. Cousens S, Smith PG, Ward H, et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001;357:1002-7.
51. Bryant G, Monk P. Final report of the investigation into the north Leicestershire cluster of variant Creutzfeldt-Jakob disease: Leicestershire NHS Health Authority. April 2001. Internet: http://www.leics-ha. org.uk/cjd/cjdbrief.htm (accessed 31 July 2002).
52. Ashraf H. UK investigators put forward theory for vCJD cluster. Lancet 2001;357(9260):937.
53. Dobson R. Traditional butchery methods linked to vCJD cluster. BMJ 2001;322(7289):753.
54. Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic in humans. Nature 1997;385:197-8.
55. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM. Epidemiological determinants of the pattern and magnitude of the vGTD epidemic in Great Britain. Proc R Soc London B Biol Sci 1998;265:2443-52.
56. Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000;406(6796):583-4.
57. Ghani AC. The epidemiology of variant Creutzfeldt-Jakob disease in Europe Microbes Infect 2002;4:385-93.
58. Klitzman RL, Alpers MP, Gajdusek DC. The natural incubation period of kuru and the episodes of transmission in three clusters of patients. Neuroepidemiology 1985;3:3-20.
59. Mead S, Mahal SP, Beck J, et al. Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet 2001;69:1225-35.
60. Stephenson DA, Chiotti K, Ebeling C, et al. Quantitative trait loci affecting prion incubation time in mice. Genomics 2000;69:47-53.
61. Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001;98:6279-83.
62. Manolakou K, Beaton J, McConnell I, et al. Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A 2001;98:7402-7.
63. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species barrier independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 2000;97:10248-53.
64. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001;7:679-84.
65. Turner ML. Variant Creutzfeldt-Jakob disease and blood transfusion Curr Opin Hematol 2001;8:372-9.
66. Bosch X. UK drug company's vCJD infected drug causes chaos in Spain. Lancet 2001;357(9256):618.
67. Gravenor MB, Cox DR, Hoinville LJ, Hoek A, McLean AR. Scrapie in Britain during the BSE years. Nature 2000;406(6796):584-5.
68. Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356:577-82.
69. Mallucci GR, Ratte S, Asante EA, et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002;21:202-10.
70. Heppner FL, Musahl C, Arrighi I, et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 2001;294:178-82.
71. Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 2001;98:9295-9.
72. Peretz D, Williamson RA, Kaneko K, et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001;412:739-43.
73. US Food and Drug Administration. Bovine spongiform encephalopathy. July 2002. Internet: http://www.fda.gov/oc/opacom/hottopics/ bse.html (accessed 31 July 2002).
74. Enserink M. Infectious diseases. Is the U.S. doing enough to prevent mad cow disease? Science 2001;292:1639-41.
75. Enserink M, Prion diseases. U.S. gets tough against chronic wasting disease. Science 2001;294:978-9.
76. Enserink M. Infectious diseases. America's own prion disease? Science 2001;292:1641.
77. Knight J. Ranches blamed over spread of mad deer. Nature 2002;416: 569-70.
78. Birmingham K. TSE threat to US increases. Nat Med 2002;8:431.
79. Gray G. The Harvard BSE Risk Assessment Study. November 2001. Internet: http://www.fda.gov/oc/bse/harvard_study.html (accessed 31 July 2002).